Pharma

Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.

Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."

The company will use the funds to create and launch new products, expand its network and speed up its growth.

Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.   

The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.

The company was founded by former Google DeepMind and Owkin scientists.

TenAces will develop an AI platform to help identify protein interactions that naturally occur in the body to assist with targeted protein degradation.

One Medical providers will be able to request drug consultations on complex medication regimens for seniors managing chronic conditions.

The proposed class action lawsuit alleges the pharmacy benefit manager worked with rival PBMs to exert its influence in the market and fix reimbursement rates and fees.

The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.